Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- KU LEUVEN
- Ghent University
- University of Antwerp
- VIB
- Vrije Universiteit Brussel
- Nature Careers
- University of Leuven
- IMEC
- Université Libre de Bruxelles (ULB)
- Vrije Universiteit Brussel (VUB)
- Hasselt University
- BIO BASE EUROPE PILOT PLANT VZW
- Flanders Institute for Biotechnology
- Ghent University;
- Univeristé Libre de Bruxelles
- University of Liège
- Université catholique de Louvain (UCL)
- Université libre de Bruxelles (ULB)
- Université libre de Bruxelles - Service BATir
- 9 more »
- « less
-
Field
-
agency and is ready to resubmit • Lives in Belgium Selection process For more information please contact Prof. dr. David Mwambari, tel.: +32 16 19 40 47, mail: david.mwambari@kuleuven.be.The application
-
25 Aug 2025 Job Information Organisation/Company University of Leuven Research Field Chemistry Physics Researcher Profile First Stage Researcher (R1) Positions PhD Positions Country Belgium
-
25 Aug 2025 Job Information Organisation/Company University of Leuven Research Field Biological sciences Medical sciences Researcher Profile First Stage Researcher (R1) Positions PhD Positions
-
25 Aug 2025 Job Information Organisation/Company University of Leuven Research Field Biological sciences Medical sciences Researcher Profile First Stage Researcher (R1) Positions PhD Positions
-
4 Sep 2025 Job Information Organisation/Company Université Libre de Bruxelles (ULB) Research Field Engineering Engineering Researcher Profile First Stage Researcher (R1) Positions PhD Positions
-
18 Sep 2025 Job Information Organisation/Company BIO BASE EUROPE PILOT PLANT VZW Department Technology Development Research Field Technology » Biotechnology Chemistry Researcher Profile First Stage
-
For more information please contact Prof. dr. ir. Eric Demeester, tel.: +32 11 75 17 75, mail: eric.demeester@kuleuven.be . Website for additional job details https://www.kuleuven.be/personeel/jobsite
-
assessment. Moreover, post-mortem studies have revealed significant molecular heterogeneity, suggesting the existence of distinct neuropathological subtypes within each disease. Stratifying patients
-
patients’ brain, molecular diagnosis during life remains challenging due to the lack of reliable biomarkers for in vivo assessment. Moreover, post-mortem studies have revealed significant molecular
-
industrial Ph.D. position focused on developing scalable, Machine Learning (ML) pipelines for genomic and epigenomic biomarker discovery from Oxford Nanopore Technologies (ONT) long-read sequencing data